# Use of Intrathecal Hydromorphone in Elective Cesarean Deliveries

> **NCT01866254** · EARLY_PHASE1 · COMPLETED · sponsor: **Grace Shih, MD** · enrollment: 45 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Hydromorphone
- **DRUG:** Morphine

## Key facts

- **NCT ID:** NCT01866254
- **Lead sponsor:** Grace Shih, MD
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2017-12-04
- **Final completion:** 2018-10-22
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2019-01-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01866254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01866254, "Use of Intrathecal Hydromorphone in Elective Cesarean Deliveries". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01866254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*